Life Sciences, deals, Stem Cells

Stem Cell Tech in Fate’s Hands

Ryan McBride 5/15/09

Fate Therapeutics, a La Jolla, CA-based biotech startup tapping advances in stem cell biology to develop new drugs, says it has gained exclusive rights to technology involving blood-forming stem cells from Children’s Hospital Boston and Massachusetts General Hospital. The hospitals jointly own the technology. Leonard Zon, director of the stem cell program at Children’s and a scientific founder of Fate, developed the stem cell technology. Randall Moon, a stem cell expert at the University of Washington, is another of several scientific founders of Fate.

Ryan McBride is Xconomy's correspondent. You can reach him at rmcbride@xconomy.com, or follow him on Twitter at http://twitter.com/Ryan_McBride.